Welcome to our dedicated page for Iveda Solutions SEC filings (Ticker: IVDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Iveda Solutions, Inc. (NASDAQ: IVDA) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. Here, investors can review Forms 10‑K and 10‑Q for detailed information on Iveda’s business, financial condition, and risk factors, along with current reports on Form 8‑K that disclose material events related to its AI video analytics, smart city, and IoT operations.
Iveda’s filings confirm that its common stock and common stock purchase warrants trade on The Nasdaq Stock Market LLC under the symbols IVDA and IVDAW. A notable Form 8‑K describes how the company received a Nasdaq notice regarding non‑compliance with certain continued listing standards tied to stockholders’ equity, market value of listed securities, or net income, and later reported stockholders’ equity above the minimum threshold, leading Nasdaq staff to determine that Iveda complied with the rules and to close the matter.
The company’s DEF 14A definitive proxy statement offers insight into corporate governance, including the annual meeting of stockholders, the election of directors, and the ratification of the independent registered public accounting firm. It also outlines record dates, voting procedures, and the rights of stockholders whose shares are held directly or in street name.
On Stock Titan, these filings are paired with AI-powered summaries that help explain complex disclosures in clear language. Users can quickly understand key points from lengthy 10‑K and 10‑Q reports, track significant 8‑K events such as listing compliance updates, and review proxy materials without reading every page. The platform also surfaces relevant information about capital structure, such as the registration of IVDA and IVDAW, and helps investors monitor how regulatory filings reflect Iveda’s evolving smart city, AI video analytics, and IoT strategies.
Iveda Solutions, Inc. files a Prospectus Supplement No. 14 dated April 1, 2026 that updates its August 30, 2022 prospectus to include the company’s Annual Report on Form 10-K for the period ended December 31, 2025 (filed March 31, 2026). The supplement covers registration language for 138,759 shares of common stock, warrants to purchase up to 411,185 shares of common stock at an exercise price of $11.20, and pre-funded warrants to purchase up to 273,685 shares of common stock, and incorporates the Form 10-K by reference.
The supplement is qualified by reference to the underlying prospectus and is intended to be read together with it, including its "Risk Factors" section. This document does not itself change offering terms; it adds the Form 10-K information to the existing prospectus package.
Iveda Solutions, Inc. files a Prospectus Supplement No. 14 to the March 31, 2022 prospectus to include its Form 10-K and to cover warrants to purchase 235,625 shares of common stock at a strike price of $34.00 per share held by stockholders identified in the prospectus.
Iveda Solutions, Inc. registers primary securities for sale. The prospectus supplement registers 5,259,999 shares of Common Stock, up to 5,714,286 Series X Warrants to purchase up to 11,428,572 shares of Common Stock, and up to 400,000 Placement Agent Warrants to purchase up to 400,000 shares. The supplement incorporates the company's Form 10-K for the period ended December 31, 2025 and updates the Prospectus effective February 9, 2026.
Iveda Solutions, Inc., now a Delaware corporation listed on Nasdaq, reports continued operating losses while positioning itself as an AI-driven smart city and IoT platform provider. For the year ended December 31, 2025, it recorded a net loss of about $3.2 million, following a $4.0 million loss in 2024, and has accumulated losses of roughly $56 million.
The company depends heavily on its Taiwan subsidiary, which generated 85% of 2025 revenue and 87% of 2024 revenue, and on a small number of large customers; four customers made up 63% of 2025 revenue. Iveda offers AI video analytics (IvedaAI), IoT platforms (Cerebro), smart power solutions, smart poles, drones, health and elder-care devices, and industrial monitoring tools.
As of March 15, 2026, Iveda had 11,139,740 shares of common stock outstanding and significant U.S. net operating loss carryforwards of about $40.0 million federal and $11.0 million state. The company highlights risks from ongoing losses, reliance on key personnel, geopolitical uncertainty around Taiwan, cybersecurity gaps, and potential Nasdaq listing compliance issues.
Iveda Solutions, Inc. has been notified by Nasdaq that its common stock no longer meets the exchange’s minimum bid price requirement of $1 per share, after trading below that level for 30 consecutive business days. The notice does not immediately affect the stock’s Nasdaq listing.
The company has 180 calendar days, until September 2, 2026, to regain compliance. Nasdaq will deem the requirement met if the closing bid price is at least $1 for a minimum of ten consecutive business days during this period. If compliance is not restored or other listing rules are breached, Nasdaq may move to delist the shares, although Iveda could appeal any delisting determination to a Nasdaq Hearings Panel.
Iveda Solutions director Robert Gillen reported offsetting option transactions tied to an option repricing. He was granted 100,000 stock options on an "acquire" transaction and disposed of 100,000 options back to the issuer on a separate "disposition to issuer" transaction, leaving 128,599 options reported as held afterward.
According to a board-approved repricing on February 23, 2026, his options were reset to an exercise price of $0.29 per share while all other terms remained unchanged. The company states these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.
Iveda Solutions Chief Financial Officer Robert J. Brilon reported changes to his stock options in a paired, non-cash transaction. He was granted 125,000 options and disposed of 125,000 options, both recorded as “Options (Right to Buy).” Following these transactions, he holds 152,503 derivative securities directly.
The company’s board approved an option repricing on February 23, 2026, resetting the exercise price of his options to $0.29 per share. The filing states that all other option terms remain unchanged and that the repricing was exempt under specific Exchange Act rules.
Iveda Solutions director Franco Alejandro reported an option repricing and related award. On February 23, 2026, the board approved a repricing of his options to an exercise price of $0.29 per share, with all other terms unchanged. This involved an acquisition of 25,000 options and a corresponding disposition of 25,000 options to the issuer, both recorded at a transaction price of $0.00 per option. Following these transactions, Alejandro directly held 53,130 options to acquire Iveda Solutions stock. The company notes these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.
Iveda Solutions, Inc. reported that Chief Executive Officer David H. Ly had his stock options repriced by the board. On February 23, 2026, options covering 175,000 shares were granted or awarded, and a separate 175,000-option position was disposed of back to the issuer. According to the disclosure, the repricing set the exercise price at $0.29 per share, while all other option terms remained unchanged. After these offsetting derivative transactions, Ly directly held options to acquire 216,096 shares.
Iveda Solutions director Joseph A. Farnsworth reported option transactions tied to an option repricing. On February 23, 2026, he acquired 100,000 stock options at an exercise price of $0.29 per share and disposed of 100,000 options back to the company, with other option terms remaining unchanged.